Old Web
English
Sign In
Acemap
>
authorDetail
>
Gregory J. Kato
Gregory J. Kato
CSL Behring
Medicine
Disease
Cell
Hemopexin
Cell-Derived Microparticles
5
Papers
2
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Gene therapy as the new frontier for Sickle Cell Disease.
2021
Current Medicinal Chemistry
Himanshu Garg
Kristina J Tatiossian
Karsten Peppel
Gregory J. Kato
Eva Herzog
Show All
Source
Cite
Save
Citations (1)
Microvascular Stasis Inhibition By Hemopexin in the Townes Mouse Model of Sickle Cell Disease
2020
Blood
Thomas Gentinetta
Gregory M. Vercellotti
Chunsheng Chen
Julia Nguyen
Fuad Abdulla
Ping Zhang
Gregory J. Kato
Nathan Brinkman
Adrian W. Zuercher
John D. Belcher
Show All
Source
Cite
Save
Citations (0)
Identifying adolescent and young adult patients with sickle cell disease at highest risk of death.
2020
American Journal of Hematology
Mark T. Gladwin
Gregory J. Kato
Victor R. Gordeuk
Show All
Source
Cite
Save
Citations (1)
Prevention of Heme-Induced Human Endothelial Cell Activation By Hemopexin in Vitro
2020
Blood
Jacqueline Adam
Thomas Gentinetta
Svetlana Diditchenko
Alexander Schaub
Gregory J. Kato
Nathan Brinkman
Adrian W. Zuercher
Show All
Source
Cite
Save
Citations (0)
1